Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Protox Therapeutics Inc T.PRX

TSX:PRX - Post Discussion

Protox Therapeutics Inc > Detailed Results
View:
Post by cabbieJBJ on Jan 25, 2010 8:34am

Detailed Results

Bioboy:

I didn't see any urine flow and prostate volume results in the NR; they were part of the prtocol. 

The NR stated:

Detailed results from this study will be presented by Professor Mostafa Elhilali during a podium session at the Annual Meeting of the American Urological Association to be held in San Francisco, May 29 - June 3, 2010.

To me that means more data is to come.
Comment by bioboy10 on Jan 25, 2010 12:19pm
You are right cabbie, May 29th is when we will get the rest of the data.Theres a buy recommendation by Dynamic Power small cap fund on PRX. Also I hear dundee has a report out as well citing the results were very good. ( anyone that has this please post ).Once the Financial over hang is out of the way it should bode well for the stock. I think they will do a small  financing at this level ...more  
Comment by risky_ventura on Feb 01, 2010 10:53am
PRX will need about $6 Million in financing to stay afloat until conference in May.  The 3-months results won't make financing easy, share dilution looks inevitable.  6-Month results should be available by mid April, in time for the conference.   I'll buy some shares if SP goes below .53. 
Comment by cabbieJBJ on Feb 01, 2010 6:11pm
Where are you getting your numbers risky?  Please enlighten the board.The cash burn should be negligible at this time.  I'm also guessing that the options were exercised in early Jan-10, yeilding about $500K.Thanks, jb
Comment by risky_ventura on Feb 02, 2010 1:53am
JB: I got my numbers from recent quartlerly financial statements.  The burn rate I indicated was likely high because, as you point out, R&D costs are probably less than in recent quarters.Net Worth or Owners Equity is on the Balance Sheet.  It equals Assets minus Liabilities.Burn Rate for a business that is developing drugs is pretty much ~ Expenses, how much it costs to run the ...more  
Comment by cabbieJBJ on Feb 02, 2010 10:06am
I think you're on the high side Risky, given that the bulk of 2B costs will be realized by Q4. Q4 results will be availble in a couple of weeks, based on historical timing.  That should give a clearer financial picture; I expect guidance and a go forward plan to be part of the CC at the very least.I also believe that any financing, if that is the preferred route, may have to await ...more